Imatinib vs Letermovir

## Imatinib vs Letermovir: Overview

This comparison examines the pharmacological differences between **Imatinib** and **Letermovir**.

## Mechanism of Action

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

## Pharmacokinetics

**Half-life**: Imatinib — 18 hours; Letermovir — N/A.

## Chemical Properties

**Molecular Formula**: Imatinib — C29H31N7O; Letermovir — N/A.

**Molecular Weight**: Imatinib — 493.6030 g/mol; Letermovir — N/A.

**Type**: Imatinib — Small molecule; Letermovir — Small molecule.